Patents Represented by Attorney, Agent or Law Firm Kevin R. Kaster
  • Patent number: 4962029
    Abstract: Oligonucleotides derivatized to incorporate horseradish peroxidase (HRP) are useful in diagnostic methods and provide significant advantage over radioactively labeled oligonucleotide probes. The HRP-derivatized oligonucleotides can be easily and efficiently prepared by reacting a sulfhydryl containing oligonucleotide with a conjugate of a mal-sac-HNSA ester and HRP under mild and easily controlled reaction conditions.
    Type: Grant
    Filed: November 16, 1989
    Date of Patent: October 9, 1990
    Assignee: Cetus Corporation
    Inventors: Corey Levenson, Chu-an Chang, Fred T. Oakes
  • Patent number: 4914210
    Abstract: Oligonucleotide functionalizing reagents are disclosed which are useful in introducing sulfhydryl, amino and additional hydroxyl groups into oligonucleotides. The reagents are substantially linear in structure, at one end provided with a phosphoramidite moiety, at an opposing end provided with a sulfhydryl, amino or hydroxyl moiety, the two ends linked through a hydrophilic spacer chain. Methods of using and synthesizing the novel reagents are disclosed as well.
    Type: Grant
    Filed: October 2, 1987
    Date of Patent: April 3, 1990
    Assignee: Cetus Corporation
    Inventors: Corey Levenson, Chu-An Chang, Fred T. Oakes
  • Patent number: 4889818
    Abstract: A purified thermostable enzyme is obtained that has unique characteristics. Preferably the enzyme is isolated from the Thermus aquaticus species and has a molecular weight of about 86,000-90,000 daltons. The thermostable enzyme may be native or recombinant and may be used in a temperature-cycling chain reaction wherein at least one nucleic acid sequence is amplified in quantity from an existing sequence with the aid of selected primers and nucleotide triphosphates. The enzyme is preferably stored in a buffer of non-ionic detergents that lends stability to the enzyme.
    Type: Grant
    Filed: June 17, 1987
    Date of Patent: December 26, 1989
    Assignee: Cetus Corporation
    Inventors: David H. Gelfand, Susanne Stoffel, Frances C. Lawyer, Randall K. Saiki
  • Patent number: 4873633
    Abstract: A host computer controls a plate reader which optically reads the results between donor samples and reagents. The system provides the user with the ability to change the position of off-center light absorbance readings to maximize the power of the machine to discriminate between positive and negative agglutination reactions. In addition, the user can tailor thresholds for absorbances used to distinguish between positive, negative and "no type determined" reactions.
    Type: Grant
    Filed: September 11, 1986
    Date of Patent: October 10, 1989
    Assignee: Cetus Corporation
    Inventors: Mezei, Louis M., Bradley S. Albom, Coppock, Stan, Stephen J. Moehle, Brent S. Noorda, Joseph T. Widunas, James A. Zeitlin
  • Patent number: 4822731
    Abstract: Nucleic acids may be labeled by complexing the alkylating moiety of a labeling reagent into a single-stranded nucleic acid to form a complex and activating the complex to cause covalent bonding between the reagent and the nucleic acid. Preferably, the labeled nucleic acid is a single-stranded hybridization probe for detecting nucleic acid sequences capable of hybridizing with a hybridizing region of the nucleic acid. Also preferably the label moiety is non-radioactive. The labeling reagent is of the formula:[A--[B--Lwhere A is an alkylating moiety, B is a divalent organic moiety of the formula: ##STR1## where Y is O, NH or N--CHO, x is a number from 1 to 4, y is a number from 2 to 4, and L is a monovalent label moiety, wherein B is exclusive of any portion of the alkylating and label moieties.Preferably A is a 4-methylene-substituted psoralen moiety, and most preferably A is a 4'-methylene-substituted-4,5',8-trimethylpsoralen moiety and L is biotin.
    Type: Grant
    Filed: January 9, 1986
    Date of Patent: April 18, 1989
    Assignee: Cetus Corporation
    Inventors: Robert M. Watson, Edward L. Sheldon, III, Richard M. Snead
  • Patent number: 4800159
    Abstract: The present invention is directed to a process for amplifying and detecting any target nucleic acid sequence contained in a nucleic acid or mixture thereof. The process comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers, extending the primers to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, and detecting the sequence so amplified. The steps of the reaction may be carried out stepwise or simultaneously and can be repeated as often as desired.In addition, a specific nucleic acid sequence may be cloned into a vector by using primers to amplify the sequence, which contain restriction sites on their non-complementary ends, and a nucleic acid fragment may be prepared from an existing shorter fragment using the amplification process.
    Type: Grant
    Filed: December 17, 1986
    Date of Patent: January 24, 1989
    Assignee: Cetus Corporation
    Inventors: Kary B. Mullis, Henry A. Erlich, Norman Arnheim, Glenn T. Horn, Randall K. Saiki, Stephen J. Scharf